Home Combined international external quality assessment results of medical laboratory performance and reporting of samples with known antimicrobial resistance
Article
Licensed
Unlicensed Requires Authentication

Combined international external quality assessment results of medical laboratory performance and reporting of samples with known antimicrobial resistance

  • Michael A. Noble EMAIL logo and Robert Rennie
Published/Copyright: June 15, 2018

Abstract

Background

Reporting on the presence of antimicrobial resistance is of considerable concern both for individual patient care and for understanding the underlying health status within the community at large. Antimicrobial resistance is solely dependent upon clinical laboratory detection and thus can be impacted upon by the quality and competence of medical laboratories. Proficiency testing or external quality assessment (PT/EQA) is the international standard for the direct measurement of medical laboratory performance on critical testing.

Methods

An international, intercontinental collaborative retrospective study of medical laboratory performance in antibiotic resistance was performed by the Microbiology Working Group (MWG) of the European Organisation for External Quality Assurance for Laboratory Medicine (EQALM) with particular examination of laboratory performance on the testing and reporting of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE) and carbapenem-resistant Enterobacteriaceae (CRE).

Results

The results of 1880 medical laboratories were compiled. Strictly accurate reporting of isolates as resistant occurred with MRSA 96.9%, with VRE 91.3% and with CRE 93.1% of the time. On the other hand, very major errors (reporting of false susceptibility) were observed with 2.2% of MRSA and 2.4% of VRE and 0.8% of CRE. Major errors (false resistance) were reported for vancomycin susceptibility testing for MRSA at a rate of 0.6%.

Conclusions

Depending on how clinical physicians read and understand microbiology susceptibility reports, proficient acceptable results were reported either between 91% and 94% of the time, or between 97% and 100%. While very major errors are infrequently reported, they were found in all regions and could potentially cause poor treatment decisions by clinicians. A collective analysis of multi-program PT/EQA information can provide valuable insights into the testing and reporting practices of medical laboratories.


Corresponding author: Michael A. Noble, MD, FRCPC, Clinical Microbiology Proficiency Testing (CMPT), Department of Pathology and Laboratory Medicine, University of British Columbia, G-409, 2211 Wesbrook Mall, Vancouver, British Columbia, Canada
aChair, Microbiology Working Group, EQALM, on behalf of EQALM Microbiology Working Group.

Acknowledgments

The authors acknowledge the leadership and support of the EQALM Scientific Committee including Piet Meijer (Netherlands, chair), Wim Coucke (Belgium), Joan-Lluis Vives Corrons (Spain), Istvan Juhos (Hungary), Ann Helen Kristoffersen (Norway) and Michael Noble (Canada), and advisor Anne Stavelin (Norway, chair EQALM).

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Van Puyvelde S, Deborggraeve S, Jacobs J. Why the antibiotic resistance crisis requires a One Health approach. Lancet Infect Dis 2017;18:132–4.10.1016/S1473-3099(17)30704-1Search in Google Scholar

2. Martens E, Demain AL. The antibiotic resistance crisis, with a focus on the United States. J Antibiot 2017;70:520–6.10.1038/ja.2017.30Search in Google Scholar PubMed

3. Perez F, Villegas MV. The role of surveillance systems in confronting the global crisis of antibiotic-resistant bacteria. Curr Opin Infect Dis 2015;28:375–83.10.1097/QCO.0000000000000182Search in Google Scholar PubMed PubMed Central

4. Ventola CL. The antibiotic resistance crisis: part 2: management strategies and new agents. P T 2015;40:344–52.Search in Google Scholar

5. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T 2015;40:277–83.Search in Google Scholar

6. Li J. Current status and prospects for in-feed antibiotics in the different stages of pork production – a review. Asian-Australas J Anim Sci 2017;30:1667–73.10.5713/ajas.17.0418Search in Google Scholar PubMed PubMed Central

7. Li N, Ho KW, Ying GG, Deng WJ. Veterinary antibiotics in food, drinking water, and the urine of preschool children in Hong Kong. Environ Int 2017;108:246–52.10.1016/j.envint.2017.08.014Search in Google Scholar PubMed

8. Fishovitz J, Hermoso JA, Chang M, Mobashery S. Penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. IUBMB Life 2014;66:572–7.10.1002/iub.1289Search in Google Scholar PubMed PubMed Central

9. Courvalin P. Vancomycin resistance in gram-positive cocci. Clin Infect Dis 2006;42(Suppl 1):S25–34.10.1086/491711Search in Google Scholar PubMed

10. Sho T, Muratani T, Hamasuna R, Yakushiji H, Fujimoto N, Matsumoto T. The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 beta-lactamase production in Japan. Microb Drug Resist 2013;19:274–81.10.1089/mdr.2012.0248Search in Google Scholar PubMed

11. Jones RN, Gavan TL, Barry AL, Thornsberry C, Gibbs DL. Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits. J Clin Microbiol 1982;15:777–86.10.1128/jcm.15.5.777-786.1982Search in Google Scholar PubMed PubMed Central

12. Cuzon G, Naas T, Nordmann P. [KPC carbapenemases: what is at stake in clinical microbiology?]. Pathol Biol (Paris) 2010;58:39–45.10.1016/j.patbio.2009.07.026Search in Google Scholar PubMed

13. Steward CD, Mohammed JM, Swenson JM, Stocker SA, Williams PP, Gaynes RP, et al. Antimicrobial susceptibility testing of carbapenems: multicenter validity testing and accuracy levels of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates. J Clin Microbiol 2003;41:351–8.10.1128/JCM.41.1.351-358.2003Search in Google Scholar

14. Thomson KS. The role of the microbiology laboratory in an era of increasing antibiotic resistance. Postgrad Med 2001; 109(2 Suppl):78–81.Search in Google Scholar

15. Borchardt JK. The history of bacterial meningitis treatment. Drug News Perspect 2004;17:219–24.10.1358/dnp.2004.17.3.829020Search in Google Scholar

16. Garrod LP. Causes of failure in antibiotic treatment. Br Med J 1972;4:473–6.10.1136/bmj.4.5838.473Search in Google Scholar

17. Hajjej Z, Gharsallah H, Naija H, Boutiba I, Labbene I, Ferjani M. Successful treatment of a Carbapenem-resistant Klebsiella pneumoniae carrying bla OXA-48, bla VIM-2, bla CMY-2 and bla SHV- with high dose combination of imipenem and amikacin. IDCases 2016;4:10–2.10.1016/j.idcr.2016.01.003Search in Google Scholar

18. Kreitmeyr K, von Both U, Pecar A, Borde JP, Mikolajczyk R, Huebner J. Pediatric antibiotic stewardship: successful interventions to reduce broad-spectrum antibiotic use on general pediatric wards. Infection 2017;45:493–504.10.1007/s15010-017-1009-0Search in Google Scholar

19. Ravi N, Laha A, Hmar L, Chatterjee S, Goswami J, Goel G, et al. Exploring the prescribing behaviours and the mind of antibiotic prescribers is critical for a successful antibiotic stewardship programme: results of a survey from Eastern India. Indian J Med Microbiol 2017;35:299–301.10.4103/ijmm.IJMM_17_133Search in Google Scholar

20. Gomes DM, Ward KE, LaPlante KL. Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus. Pharmacotherapy 2015;35:424–32.10.1002/phar.1577Search in Google Scholar

21. Poveda Gabaldon M, Ovies MR, Orta Mira N, Serrano Mdel R, Avila J, Gimenez A, et al. [Implementation of quality standard UNE-EN ISO/IEC 17043 in the External Quality Control Program of the Spanish Society of Infectious Diseases and Clinical Microbiology]. Enfermedades Infecciosas y Microbiologia Clinica 2011;29(Suppl 5):76–81.10.1016/S0213-005X(11)70047-7Search in Google Scholar

22. International Organization for Standardization. ISO/IEC 17043:2010 (Conformity assessment – General requirements for proficiency testing). Geneva, Switzerland: ISO, 2010.Search in Google Scholar

23. Richardson H, Noble MA, Fleming CA, Nikiforuk S, Mackenzie AM, Committees M. An interprovincial external quality assessment of the ability of Canadian laboratories to detect the vancomycin and penicillin resistance of Enterococcus faecium D366. Clin Microbiol Infect 1999;5:424–30.10.1111/j.1469-0691.1999.tb00166.xSearch in Google Scholar PubMed

24. M23 – Development of in vitro susceptibility testing criteria and quality control parameters, 4th ed. Wayne, PA 19087, USA: Clinical and Laboratory Standards Institute, 2016.Search in Google Scholar

Received: 2018-05-07
Accepted: 2018-05-23
Published Online: 2018-06-15
Published in Print: 2018-09-25

©2018 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 17.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/dx-2018-0020/html
Scroll to top button